LLM enhanced graph inference for long-term disease progression modelling

TL;DR

This paper introduces a novel framework that leverages Large Language Models to improve long-term disease progression modeling by better capturing complex brain region interactions in neurodegenerative diseases.

Contribution

The study presents a new LLM-guided approach that enhances graph learning for disease modeling, addressing limitations of traditional methods and improving prediction accuracy and interpretability.

Findings

Outperforms traditional models in predicting Alzheimer's disease progression.

Reveals additional disease-driving factors beyond standard connectivity measures.

Provides more biologically plausible and interpretable disease trajectories.

Abstract

Understanding the interactions between biomarkers among brain regions during neurodegenerative disease is essential for unravelling the mechanisms underlying disease progression. For example, pathophysiological models of Alzheimer's Disease (AD) typically describe how variables, such as regional levels of toxic proteins, interact spatiotemporally within a dynamical system driven by an underlying biological substrate, often based on brain connectivity. However, current methods grossly oversimplify the complex relationship between brain connectivity by assuming a single-modality brain connectome as the disease-spreading substrate. This leads to inaccurate predictions of pathology spread, especially during the long-term progression period. Meanhwile, other methods of learning such a graph in a purely data-driven way face the identifiability issue due to lack of proper constraint. We thus present a novel framework that uses Large Language Models (LLMs) as expert guides on the interaction of regional variables to enhance learning of disease progression from irregularly sampled longitudinal patient data. By leveraging LLMs' ability to synthesize multi-modal relationships and incorporate diverse disease-driving mechanisms, our method simultaneously optimizes 1) the construction of long-term disease trajectories from individual-level observations and 2) the biologically-constrained graph structure that captures interactions among brain regions with better identifiability. We demonstrate the new approach by estimating the pathology propagation using tau-PET imaging data from an Alzheimer's disease cohort. The new framework demonstrates superior prediction accuracy and interpretability compared to traditional approaches while revealing additional disease-driving factors beyond conventional connectivity measures.